Quick Answer
CorMedix Inc. reported Stockholders Equity of $405.31 million for the year ending 2025.
- CorMedix Inc. showed an increase of +378.8% in Stockholders Equity from 2024 to 2025.
- This data is from CorMedix Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2006 to 2025 (20 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2011: $1.24 million | Q1 2012: $423.0 thousand | Q3 2012: -$116.8 thousand | Q1 2013: -$1.28 million | Q2 2013: -$2.19 million | Q3 2013: -$2.91 million | Q1 2014: -$3.73 million | Q2 2014: -$1.60 million | Q3 2014: $5.58 million | Q1 2015: $7.60 million | Q2 2015: $36.85 million | Q3 2015: $36.39 million | Q1 2016: $30.52 million | Q2 2016: $28.07 million | Q3 2016: $23.78 million | Q1 2017: $11.04 million | Q2 2017: $15.37 million | Q3 2017: $9.68 million | Q1 2018: $840.7 thousand | Q2 2018: -$6.48 million | Q3 2018: -$9.50 million | Q1 2019: $16.54 million | Q2 2019: $16.48 million | Q3 2019: $28.71 million | Q1 2020: $21.59 million | Q2 2020: $18.52 million | Q3 2020: $34.47 million | Q1 2021: $80.32 million | Q2 2021: $76.87 million | Q3 2021: $69.34 million | Q1 2022: $59.87 million | Q2 2022: $61.74 million | Q3 2022: $56.31 million | Q1 2023: $53.93 million | Q2 2023: $49.05 million | Q3 2023: $83.20 million | Q1 2024: $58.01 million | Q2 2024: $46.18 million | Q3 2024: $58.71 million | Q1 2025: $114.89 million | Q2 2025: $220.63 million | Q3 2025: $374.13 million.
- Over the full 20 years of available data (2006 to 2025), CorMedix Inc.'s Stockholders Equity has grown by 42,049.9%.
- Historical annual values: Fiscal year 2025: $405.31 million | Fiscal year 2024: $84.66 million | Fiscal year 2023: $70.14 million | Fiscal year 2022: $55.06 million | Fiscal year 2021: $62.80 million | Fiscal year 2020: $44.22 million | Fiscal year 2019: $23.65 million | Fiscal year 2018: $4.93 million | Fiscal year 2017: $7.19 million | Fiscal year 2016: $17.81 million | Fiscal year 2015: $34.01 million | Fiscal year 2014: $3.63 million | Fiscal year 2013: -$4.02 million | Fiscal year 2012: -$335.4 thousand | Fiscal year 2011: $1.24 million | Fiscal year 2010: $7.26 million | Fiscal year 2009: -$14.71 million | Fiscal year 2008: -$12.03 million | Fiscal year 2007: -$4.40 million | Fiscal year 2006: -$966.2 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: